Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.

@article{Brunetti2010IncidenceOS,
  title={Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.},
  author={Paolo Brunetti and Vito Michele Rosario Muggeo and Luigi Cattin and Andrea Arcangeli and Paolo Pozzilli and Vincenzo Provenzano and Arianna Francesconi and P. Calatola and Fausto Santeusanio},
  journal={Nutrition, metabolism, and cardiovascular diseases : NMCD},
  year={2010},
  volume={20 7},
  pages={
          519-26
        }
}
BACKGROUND AND AIMS Once-daily (OD) basal insulin glargine (GLA) can be used as part of a multiple daily injection regimen in patients with type 1 diabetes mellitus. This randomized, multicenter study compared GLA+prandial regular human insulin (RHI) with GLA+prandial insulin lispro (LIS) in reducing the incidence of severe nocturnal hypoglycemia at endpoint. In addition, the effects on glycemic control of both treatments were investigated. METHODS AND RESULTS Patients (489) previously on… CONTINUE READING
BETA

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy

  • EA Gale
  • The UK Trial Group. Diabet Med
  • 2000
Highly Influential
9 Excerpts

16 - week comparison of the novel insulin analog insulin glargine ( HOE 901 ) and NPH human insulin used with insulin lispro in patients with type 1 diabetes

  • E Mannucci, V Ricci, G Bardini, CM Rotella
  • Diabetes Care
  • 2000

Similar Papers

Loading similar papers…